Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review

Date: May 2, 2017
Pages: 47
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N2865AFDEE0EN
Leaflet:

Download PDF Leaflet

Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review
Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Natco Pharma Ltd (Natco Pharma) focuses on the research, development, manufacture and commercialization of pharmaceutical substances and finished dosage forms. The company offers finished dosage forms in capsule, injection and tablet forms. Its products are indicated to treat multiple sclerosis, influenza infection, multiple myeloma, leukemia, Crohn's disease, hypertension, Myelodysplastic syndrome and prostate cancer and others. Natco Pharma offers active pharmaceutical ingredients (APIs) for the domestic and international markets. It manages five API and finished dosage facilities and a research center in India. The company operates in India, the US, Canada, and Europe. Natco Pharma is headquartered in Hyderabad, Telangana, India.

Natco Pharma Ltd Key Recent Developments

Feb 14,2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017
Jan 25,2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility
Nov 11,2016: NATCO records INR 467.86 Crore operating revenue for the Second Quarter, FY 2017, ended September 2016
Aug 25,2016: NATCO receives Establishment Inspection Report for Chennai facility
Aug 16,2016: Natco Receives Establishment Inspection Report For Kothur Facility

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Natco Pharma Ltd - Key Facts
Natco Pharma Ltd - Key Employees
Natco Pharma Ltd - Key Employee Biographies
Natco Pharma Ltd - Major Products and Services
Natco Pharma Ltd - Pharmaceutical Pipeline Products Data
Natco Pharma Ltd, Pipeline Products by Therapy Area
Natco Pharma Ltd, Pipeline Products by Development Phase
Natco Pharma Ltd - History
Natco Pharma Ltd - Company Statement
Natco Pharma Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Natco Pharma Ltd - Business Description
Natco Pharma Ltd - Corporate Strategy
Natco Pharma Ltd - SWOT Analysis
SWOT Analysis - Overview
Natco Pharma Ltd - Strengths
Natco Pharma Ltd - Weaknesses
Natco Pharma Ltd - Opportunities
Natco Pharma Ltd - Threats
Natco Pharma Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Natco Pharma Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 14, 2017: NATCO records INR 685.13 Crore total consolidated revenue and INR 194.76 Crore of profit, after tax, for the Third Quarter, FY 2017 14 February 2017
Jan 25, 2017: NATCO updates on USFDA inspection at its Kothur Formulation Facility
Nov 11, 2016: NATCO records INR 467.86 Crore operating revenue for the Second Quarter, FY 2017, ended September 2016
Aug 25, 2016: NATCO receives Establishment Inspection Report for Chennai facility
Aug 16, 2016: Natco Receives Establishment Inspection Report For Kothur Facility
Aug 09, 2016: Natco Pharma Announces First quarter Results for 2016
May 26, 2016: Natco Pharma Announces Q4 & FY16 Results
Mar 27, 2016: Natco updates on USFDA Inspection
Feb 11, 2016: NATCO records Rs.281.40 crores revenue for the Third Quarter, ended December 2015

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Natco Pharma Ltd, Key Facts
Natco Pharma Ltd, Key Employees
Natco Pharma Ltd, Key Employee Biographies
Natco Pharma Ltd, Major Products and Services
Natco Pharma Ltd, Number of Pipeline Products by Therapy Area
Natco Pharma Ltd, Number of Pipeline Products by Development Stage
Natco Pharma Ltd, History
Natco Pharma Ltd, Other Locations
Natco Pharma Ltd, Subsidiaries
Natco Pharma Ltd, Joint Venture
Natco Pharma Ltd, Key Competitors
Natco Pharma Ltd, Ratios based on current share price
Natco Pharma Ltd, Annual Ratios
Natco Pharma Ltd, Annual Ratios (Cont.1)
Natco Pharma Ltd, Annual Ratios (Cont.2)
Natco Pharma Ltd, Interim Ratios
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Natco Pharma Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Natco Pharma Ltd, Pipeline Products by Therapy Area
Natco Pharma Ltd, Pipeline Products by Development Phase
Natco Pharma Ltd, Performance Chart (2012 - 2016)
Natco Pharma Ltd, Ratio Charts
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Natco Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Suven Life Sciences Ltd
Piramal Enterprises Ltd
Medicamen Biotech Ltd
Jubilant Life Sciences Ltd
Divi's Laboratories Ltd
Cipla Ltd
Biocon Ltd
Skip to top


Ask Your Question

Natco Pharma Ltd (NATCOPHARM) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: